• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

N Engl J Med. Covid-19 in Critically Ill Patients in the Seattle Region - Case Series

tetano

Editor, Senior Moderator
N Engl J Med. 2020 Mar 30. doi: 10.1056/NEJMoa2004500. [Epub ahead of print]
Covid-19 in Critically Ill Patients in the Seattle Region - Case Series.


Bhatraju PK[SUP]1[/SUP], Ghassemieh BJ[SUP]1[/SUP], Nichols M[SUP]1[/SUP], Kim R[SUP]1[/SUP], Jerome KR[SUP]1[/SUP], Nalla AK[SUP]1[/SUP], Greninger AL[SUP]1[/SUP], Pipavath S[SUP]1[/SUP], Wurfel MM[SUP]1[/SUP], Evans L[SUP]1[/SUP], Kritek PA[SUP]1[/SUP], West TE[SUP]1[/SUP], Luks A[SUP]1[/SUP], Gerbino A[SUP]1[/SUP], Dale CR[SUP]1[/SUP], Goldman JD[SUP]1[/SUP], O'Mahony S[SUP]1[/SUP], Mikacenic C[SUP]1[/SUP].

Author information




Abstract

BACKGROUND:

Community transmission of coronavirus 2019 (Covid-19) was detected in the state of Washington in February 2020.
METHODS:

We identified patients from nine Seattle-area hospitals who were admitted to the intensive care unit (ICU) with confirmed infection with severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). Clinical data were obtained through review of medical records. The data reported here are those available through March 23, 2020. Each patient had at least 14 days of follow-up.
RESULTS:

We identified 24 patients with confirmed Covid-19. The mean (?SD) age of the patients was 64?18 years, 63% were men, and symptoms began 7?4 days before admission. The most common symptoms were cough and shortness of breath; 50% of patients had fever on admission, and 58% had diabetes mellitus. All the patients were admitted for hypoxemic respiratory failure; 75% (18 patients) needed mechanical ventilation. Most of the patients (17) also had hypotension and needed vasopressors. No patient tested positive for influenza A, influenza B, or other respiratory viruses. Half the patients (12) died between ICU day 1 and day 18, including 4 patients who had a do-not-resuscitate order on admission. Of the 12 surviving patients, 5 were discharged home, 4 were discharged from the ICU but remained in the hospital, and 3 continued to receive mechanical ventilation in the ICU.
CONCLUSIONS:

During the first 3 weeks of the Covid-19 outbreak in the Seattle area, the most common reasons for admission to the ICU were hypoxemic respiratory failure leading to mechanical ventilation, hypotension requiring vasopressor treatment, or both. Mortality among these critically ill patients was high. (Funded by the National Institutes of Health.).
Copyright ? 2020 Massachusetts Medical Society.



PMID:32227758DOI:10.1056/NEJMoa2004500
 
Back
Top